Paydirt
KA
Insider

Kaitlyn Arsenault

Chief Financial Officer

Kaitlyn Arsenault (Chief Financial Officer) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in SKYE. The largest single filing was $216K of SKYE (43,206 sh × $4.99, as filed), executed Nov 18 2024.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells · 1 late
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$430K
shares × price, as filed
Last traded
Nov 18 2024
Filed Feb 28 2025
Open performance
Volume by month
$216K$108K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $216KFeb 2025 · sells $215K
Buys $0 Sells $430K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 2 filings

Sector per market data · by filing · past 24 months

Most traded names
SKYE SKYE SKYE · 0 buys · 2 sells 2 filings
Recent filings
SKYESALE Skye Bioscience, Inc. View filing → $215K
43,026 sh × $4.99
Exec Nov 18 2024
Filed Feb 28 2025 · 5:30 PM ET †
SKYESALE Skye Bioscience, Inc. View filing → $216K
43,206 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET